Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.093 | 0.1 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |